Working with WHO to resolve issues: Bharat Biotech on Covaxin delay
Hyderabad-based Bharat Biotech today that it is diligently working with the World Health Organisation (WHO) to obtain Emergency Use Listing (EUL) at the earliest.
It said that it is not “appropriate to speculate” on the regulatory approval process and the timelines.
“As a responsible manufacturer with past approvals for our other vaccines, we do not find it appropriate to speculate or comment on the regulatory approval process & its timelines,” it said.
It said that an appropriate times, the company will make announcements to indicate the availability of regulatory approvals.
“We request media organizations to exercise restraint while reporting on public health related issues and timelines, as it has an impact on millions of lives and livelihoods,” it further said.